Credentials

  • Chief Medical Officer, Georgia Detox & Recovery Centers
  • Medical Director, Bluff Plantation
  • Chief of Addiction Medicine, Department of Psychiatry and Health Behavior, Medical College of Georgia at Augusta University
  • Triple board certified, Anesthesiology, Pain Medicine, and Addiction Medicine
  • Phi Beta Kappa, Magna Cum Laude University of Georgia undergraduate
  • Graduate of the Medical College of Georgia
  • Resident, Anesthesiology, University of Alabama-Birmingham
  • Award Recipient: Dripps Award for the Best Anesthesiology Resident
  • National expert, testifying on Capitol Hill on MDMA and prescription misuse and abuse
  • Served the State of Florida and its Drug Czars
  • Medical and scientific consultant, US Senate Crime and Drugs Subcommittee, and the Department of Labor
  • Testified and consulted for the DEA on safe prescribing of narcotic drugs and the model of ideal treatment programs
  • Medical Director, non-profit, profit, and academic chemical dependency and dual diagnosis detoxification and stabilization, residential, partial hospitalization, intensive outpatient, and hospital programs
  • Chief Medical Officer, Medical Director, Gateway Community & Rehabilitation Services (Jacksonville), Wekiva Springs Psychiatric Hospital (Jacksonville), Stewart Marchman (Daytona), Lakeview (Jacksonville), Stepping Stone (Jacksonville), Nancy Reagan TPC Village (Jacksonville)
  • Attending Physician, UF Health Vista West Dual Diagnosis unit (Gainesville) and River Region Methadone Maintenance Program (Jacksonville)
  • Monitoring physician, Florida Board of Medicine
  • Evaluator and treatment provider, Florida Professionals Resource Network, Intervention Project for Nurses, and Lawyers Assistance programs
  • Member, Drug Free America Foundation Board of Directors
  • Founder, NexStep Integrated Pain Care Inc.
  • Associate Professor in Psychiatry and Addiction Medicine
  • National forensic expert in iatrogenic addiction and accidental overdose, injury and death as well as tobacco
  • Principal investigator or co-PI for the Florida site of the pivotal trials for bupropion vs placebo in smoking cessation as well as in pharmacological studies of naltrexone, depression, OCD, and anxiety
  • Author, peer reviewed scientific papers, abstracts, textbook chapters including the ASAM and APA definitive substance use volumes, and practice guidelines including highly cited studies on mitigating opioid abuse in chronic pain treatment, physician recovery, naltrexone, urine drug testing, and body mass index and alcohol use